Item 9 Labs Corp.
INLB · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.8% | 170.1% | 64.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.6% | 39.3% | 40.6% | 48.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -104.9% | -19.8% | -54.8% | -181% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -143.1% | -49.7% | -151.4% | -215.5% |
| EPS Diluted | -0.33 | -0.14 | -0.2 | -0.17 |
| % Growth | -135.7% | 30% | -17.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |